Theodrenaline
|
WikiDoc Resources for Theodrenaline |
|
Articles |
|---|
|
Most recent articles on Theodrenaline Most cited articles on Theodrenaline |
|
Media |
|
Powerpoint slides on Theodrenaline |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Theodrenaline at Clinical Trials.gov Trial results on Theodrenaline Clinical Trials on Theodrenaline at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Theodrenaline NICE Guidance on Theodrenaline
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Theodrenaline Discussion groups on Theodrenaline Patient Handouts on Theodrenaline Directions to Hospitals Treating Theodrenaline Risk calculators and risk factors for Theodrenaline
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Theodrenaline |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Theodrenaline (INN), also known as noradrenalinoethyltheophylline, is a chemical linkage of norepinephrine (noradrenaline) and theophylline used as a cardiac stimulant. It is sometimes combined with cafedrine.
